Breast Cancer Clinical Trials

Showing 3661-3680 of 5,597 trials

F-18 16 Alpha-Fluoroestradiol-Labeled Positron Emission Tomography in Predicting Response to First-Line Hormone Therapy in Patients With Stage IV Breast Cancer

NCT00602043

This phase II trial is studying how well F-18 16 alpha-fluoroestradiol (FES) imaging works in predicting response to first-line hormone therapy in women with hormone receptor-positive metastatic breast cancer. Diagnostic procedures, such as FES imaging, may help predict how well patients will respond to hormone therapy and may help plan the best treatment.

Estrogen Receptor-positive Breast CancerProgesterone Receptor-negative Breast CancerProgesterone Receptor-positive Breast Cancer+2 more

National Cancer Institute (NCI)20 participantsStarted Sep 2008

Seattle, Washington, United States

COMPLETED

A Study to Develop Predictive and Prognostic Tools for Optimizing Therapy With Bevacizumab Frontline Cancer Therapy in Participants With HER 2-Negative Aggressive Metastatic Breast Cancer

NCT02613208

This multicenter, observational, prospective study will identify a powerful and easy predictive/prognostic marker to use with participants under bevacizumab.

Breast Cancer

Hoffmann-La Roche111 participantsStarted Dec 2015

Palma de Mallorca, Balearic Islands, Spain • Castellon, Castellon, Spain • Córdoba, Cordoba, Spain +22 more locations

F-18 16 Alpha-Fluoroestradiol-Labeled Positron Emission Tomography in Predicting Response to First-Line Hormone Therapy in Patients With Stage IV Breast Cancer

A Study to Develop Predictive and Prognostic Tools for Optimizing Therapy With Bevacizumab Frontline Cancer Therapy in Participants With HER 2-Negative Aggressive Metastatic Breast Cancer

Related Searches

Vaccine Therapy in Treating Patients Receiving Trastuzumab For HER2-Positive Stage IIIB-IV Breast Cancer

Making Activity Time for Cognitive Health

Cancer/Testis Antigen Immunotherapy Phase I Study With 740-CTA Vaccinia Virus

Using Technology to Improve Physical Activity Levels Among Postmenopausal Women (The Active & Aware Study)

FALSE POSITIVE FINDINGS IN BREAST CANCER TOMOSYNTHESIS

Pyrotinib in Breast Cancer Patients With Poor Response to the Neoadjuvant Treatment of Trastuzumab and Pertuzumab

Study to Compare the Effects of AZD9496 vs Fulvestrant in Breast Cancer.

A Study on Optimizing Follow-up for Postmenopausal Women With Breast Cancer Treated With Adjuvant Endocrine Therapy

Pertuzumab in First Line Treatment of HER2-positive Metastatic Breast Cancer Patients

Vaccine Plus Montanide ISA-51 and Sargramostim in Treating Patients With Stage IV Breast Cancer

Capecitabine Plus Pyrotinib Versus Capecitabine Plus Trastuzumab and Pertuzumab in the First-line Treatment of HER2-positive Metastatic Breast Cancer

Safety and Pharmacokinetics of Atezolizumab Combination Treatments in Participants With HER2-Positive and HER2-Negative Breast Cancer

F18 EF5 PET/CT Imaging in Patients With Brain Metastases From Breast Cancer

DIG-HIF-1 Pharmacodynamic Trial in Newly Diagnosed Operable Breast Cancer

The Effects of Anesthetics on Persistent Pain Following Breast Cancer Surgery

Stress, Diurnal Cortisol, and Breast Cancer Survival

Capecitabine in Treating Patients With Metastatic Breast Cancer

Post Mastectomy Pain Syndrome After Preoperative Stellate Ganglion Block for Breast Cancer Surgeries